Member Info for keiny1

Sorry for your loss Ahfam, best wishes to you and family.

Ah same old same old...seems SCLP can never keep a positive sentiment going, even when news is there to then add some nice PR too. LTH's are used to this being the case now, but it doesn't make it less frustrating for us. When we think things are turning the corner, the BOD has rarely helped on the PR front with any prolonged drive.

There is explosive potential, however, previously while i was hoping for a total company value of approx $3Bn ($1Bn for each major pipeline ish). I'd take $1Bn this year for a TO...it's simply been too long in the making and waiting endlessly, but of course not saying it isn't worth more, just being realistic of where the BOD can actually get the SP/MCAP. Even a seemingly paltry $1 sp would be a tempting exit point for me personally now. Each to their own tho and GLA.

SAR Bod had very little to do with the agreement made with Sierra, this was negogiated by CRUK. Even the more recent re-negogiation probably allowed very little input from SAR again. At the time of the agreement I'm sure CRUK were told all that they wanted to hera with regards to how Sierra would progress into clinical trials only for that to now obviously have been half truths at best. The data for combos is there and is likley what will be the commercialisation of 737, but it's been a frustrating wait for all. Hoping news comes of concrete progression ideally before xmas, othwerwise early 2022.

Frustrating also to see the SP slide and no visible attempt by the BOD to stop this and give further updates, however, it's a murky old world this Pharma sector and it's also at times painfully slow when you have been teased with some great potential surfacing.

GLA, maybe not the xmas time joy we were hoping for, but 'one day rodney'

That’s the positive, looks to be coming back in some form… does anyone know more… anyone at the AGM?

That large 'Buy' is the sale of the options, shows as a buy due to timing and sp spread at the time it was reported.
Feel this is just a clearing up of exercising options as they can and the potential to be in a closed period in the coming weeks when they woul dbe unable to undertake the same. GLA

Thanks for highlighting that a downside exists, but it's not mentioned here because any halfwit can tell you that the downside of a small bio is a 100% loss. Most people here have that half of a brain and are fully aware, so no need to mention...it'd be like saying 'Do you know the night sky is black? The licensing and TO deals are currently for pre-clinical pipelines and yes $Billions have been spent by Major pharmas on those and this is what we are here for currently - hence the optimissim with the current IP and patent coberage SAR have with historic data being nothing but positive. GLA LTH's

Notalot - Best wishes also and anyone else currently dealing with a horrible disease.

Not really with you on that line of thought… sure if we had no RNS abs the usual steady sentiment today would not be bad but having had the RNS this IMO should be up. Trials have been know you stop before they’ve even started, so it’s still very good news, which I don’t feel has been included already due to the difficulties of recruiting and starting trials in the current environment. Looking for a 10-15% rise here in the next couple of weeks as further positions are taken by interested parties. GLA

I think all holders are disappointed with the sp reaction today… I was pessimistic and hoping for 5~10% rise and that didn’t even come. Ah well, trial is commenced and let’s see how we go in the next couple of months!

Hi Pistol, thanks for the insights and notes regarding the event you were at all interesting in terms of how smaller pharmas need to think or set things up. The thing I cannot quite believe is that they know nothing of Scancell's work, being within the same sector and particulary, you would think doing their own DD and research into competitors and peers? Seems very odd, but anyway, they will hopefully be fully aware soon.. GLA, the trial data cant come quick enough now it's in progress!

Cheers elcap

Am I right on thinking that the undisclosed patent application will be available for public acces soon? Hoping it sheds some more light on little Sareum!

*potential , but hopefully potent treatments too ha

It’s good to see SCLP increasingly getting more exposure and very interesting is the fact we are yet to be partnered yet still notes as one of the high potential hot bios at the moment. It’s inconceivable that multiple of the major pharmas have not requested at least an informal discussion on the potent licensing and timelines.

Great interview, the only thing I’d say is that I don’t think SCLP will be going alone in the later trials and expecting a license deal or full TO of Modi Platform.

Wish I could predict timelines on deals because I need to buy a house in the next 12 months! GLA

PR and RNS deliveries have always been dire, even when super positive, they do somehow dull it down. Here for the actual Covid news when it lands to value at least part of the pie and see what occurs with the mega cancer designated platform…. But BOD could do better! GLA, let’s get back up towards 10p with a piece of news that even they can’t dull down!

CrestEx, I can understand the thought however, if that was the case I think it may have included any info on Flt3 compound also, as well as a more upbeat forward looking 'potential' comment. I think the for sale sign has for sure been ordered, butt their not quite ready to put it out yet until either 1) signing a significant licensing deal on one of the compounds or 2) releasing top notch proven data from the first trials. We wait and see, what the next 6-8 weeks bring, I think something has to give in this time frame, ideally a bidding war :) GLA

Thanks Moneywise, well aware what is going on, been here a looong time and enjoying the last 6 months for sure. Just a tongue in cheek comment at the MMs really. Very relaxed but as ever, the sooner the better lol. GL

Ok, we've had the little retrace and I doubt much more have been sold than bought so back up please MM's, keep the ball rolling and lets get nearer 10p before any significant news! GLA

I'd be happy with either as a partner or TO at $3BN, also relatively cheap for them with the cash in hand :).

Heres hoping GLA

Avidimab I mean.

Violindog, hoping that £1 comes from the first meaningful commercial agreement… ideally .. or selfishly again I’m hoping $1bn valuations for each of Covid, Modi, Adivab really, but may top slice depending on that first valuation! Also hoping that there’s a full TO sooner rather than later… but I guess I’m getting a little impatient! GLA